ARUP Newsroom

A donor collection specialist at the ARUP Blood Services Donor Center in Sandy bandages a donor’s arm after she has finished donating blood. ARUP is seeking donations of O-positive and O-negative blood to help address a critical shortage.

President and Chief Medical Officer Tracy George, MD, worked with ARUP’s PharmaDX and Clinical Trials group to create the central pathology review offering used in clinical trials for AYVAKIT. The new precision therapy for advanced systemic mastocytosis recently earned approval from the U.S. Food and Drug Administration.

Adam Barker, PhD, has been named ARUP’s first chief scientific officer. He moves into the role after having spent four years as director of Research and Development.

A former employee chats with CEO Sherrie L. Perkins, MD, PhD (center), during a reception on June 24, 2021, to celebrate Perkins’ retirement after 31 years at ARUP and the University of Utah.

New Infectious Diseases Society of America guidelines, authored by a panel led by ARUP’s Kimberly Hanson, MD, MHS, describe the benefits and limitations of COVID-19 rapid antigen testing. The expert panel suggests that standard nucleic acid amplification testing should be used instead of rapid antigen tests in most circumstances when possible.